Back to Rankings

NHC

National HealthCareB
NYSE American / Health Care Equipment & Services
Last Price
At close
2026-06-11
View Chart

AI scenario view

RankAlpha Sentiment Codex
B+
Bull case
25%
Probability
Target price
$195.00
+1.5% vs current
Most likely
B
Base case
50%
Probability
Target price
$178.00
-7.3% vs current
B-
Bear case
25%
Probability
Target price
$155.00
-19.3% vs current

AI sentiment snapshot

Latest data as of 2026-05-04
Recent news sentiment (30D)
-30.2
Negative
Company
-
Unavailable
Macro
-30.2
Negative
Pulse
-
Unavailable
Sentiment proxy
+36.2
Score

AI commentary

Headline flow is active enough to justify medium buzz because of the April 21, 2026 acquisition announcement and the late-February year-end earnings release, but this T+3 earnings follow-up remains a tentative monitoring run. No confirmed Q1 2026 company earnings source, no verified consensus surprise, no immediate price-reaction attribution, and no clear analyst revision set were available in the checked sources through May 4, 2026. That absence is not positive evidence; it lowers confidence and keeps focus on financing, leverage, and execution around the NHI transaction.

RankAlpha Sentiment Codex - 2026-05-04
Open full AI memo

Evidence flagged

peer set is too generic or lacks enough direct operating comparators; later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence

Impact
tentative
Confidence
-

AI events

2026-05-15catalystQ1 2026 earnings confirmation remains an evidence gapMedium impact

This was a scheduled T+3 earnings follow-up for a May 1, 2026 earnings date, but no Q1 2026 company earnings release, 8-K earnings exhibit, or 10-Q was confirmed in the checked sources through May 4, 2026; when filed, that release is the next meaningful thesis-updating checkpoint rather than a positive signal by itself.

2026-05-29eventNHI facility purchase review-period and financing milestoneHigh impact

NHC agreed on April 21, 2026 to buy 35 currently leased facilities from NHI for $560 million, with a review period running to May 29, 2026 and expected funding partly through a new credit facility; closing, financing terms, and any change in purchase economics are the clearest near-term drivers [#8-K-2026-04-22].

2026-08-15catalyst2025 operating base improved, but must absorb acquired assetsMedium impact

The year-end filing and company-reported 2025 earnings support that NHC entered 2026 from a larger operating base after White Oak and same-facility gains, but the next leg depends on sustaining margins and cash flow while absorbing the NHI real-estate transaction [#10-K-2026-02-26].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-05-04 • Updated nightlySource: Internal modelMethodology